These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7335366)

  • 21. Beta-interferon, retinoids and tamoxifen as maintenance therapy in metastatic breast cancer. A pilot study.
    Recchia F; Rea S; Pompili P; Casucci D; Rea MJ; Rizzo F; Gulino A; Frati L
    Clin Ter; 1995 Oct; 146(10):603-10. PubMed ID: 8585877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Combination drug-hormone therapy of the advanced stages of breast carcinoma].
    Fazio M; Cavallero P; Rattalino G; Sartoris S; Vergnano F
    Minerva Ginecol; 1976; 28(7-8):623-9. PubMed ID: 1037112
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hormone-drug therapy combination in the treatment of breast cancer].
    Pérez Manga G; Madrigal Alonso PL; Pérez Gómez FJ
    Acta Oncol (Madr); 1975 Dec; 10(3):153-68. PubMed ID: 1211117
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effectiveness of combination hormonal therapies in advanced or recurrent breast cancer--a randomized trial of tamoxifen (TAM), medroxyprogesterone acetate (MPA), their simultaneous combination, and an alternating sequential combination of TAM plus MPA].
    Sonoo H; Senoo T; Nishiki M; Morimoto T; Takashima S
    Gan To Kagaku Ryoho; 1996 Mar; 23(4):447-54. PubMed ID: 8678496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy of implantable injection port for advanced breast cancer patients].
    Nakamura S; Itoh M; Ohigashi S; Nishio T; Abe O; Sakurai K
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1529-32. PubMed ID: 8854798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Administration method and recurrence-preventing effect of medroxyprogesterone acetate (MPA) as a postoperative adjuvant endocrine therapy for stage III breast cancer. Kitakyushu Collaborative Study Group for Breast Cancer].
    Mitsuyama S; Kuroda Y; Ohsato K; Nakamura Y; Murakami F; Nishikata F; Ikeda S; Egami T; Mori A; Ohe H
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1153-60. PubMed ID: 8751803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Third-line chemotherapy with mitomycin, vinblastine, and carmustine (BCNU) in refractory breast carcinoma: a pilot study.
    Veronesi A; Tirelli U; Galligioni E; Trovò MG; Crivellari D; Donatella Magri M; Roncadin M; Tumolo S; Grigoletto E
    Cancer Treat Rep; 1982 Mar; 66(3):559-61. PubMed ID: 7060044
    [No Abstract]   [Full Text] [Related]  

  • 28. Phase II Study of AMSA, prednisone, and chlorambucil (APC) in the treatment of refractory breast cancer: a Northern California Oncology Group Study.
    Friedman MA; Marcus F; Kohler M; Resser KJ
    Cancer Treat Rep; 1982 May; 66(5):1235-6. PubMed ID: 7083225
    [No Abstract]   [Full Text] [Related]  

  • 29. L-phenylalanine mustard, doxorubicin, and vincristine in advanced breast cancer: a pilot study.
    Tormey DC; Bull JM; Lipman ML
    Cancer Treat Rep; 1980; 64(8-9):1015-6. PubMed ID: 7448819
    [No Abstract]   [Full Text] [Related]  

  • 30. Superiority of letrozole to tamoxifen in the first-line treatment of advanced breast cancer: evidence from metastatic subgroups and a test of functional ability.
    Mouridsen H; Sun Y; Gershanovich M; Perez-Carrion R; Becquart D; Chaudri-Ross HA; Lang R
    Oncologist; 2004; 9(5):489-96. PubMed ID: 15477633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy and tamoxifen for breast cancer.
    N Engl J Med; 1981 Oct; 305(17):1014-5. PubMed ID: 7278914
    [No Abstract]   [Full Text] [Related]  

  • 32. Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen.
    Goss PE; Ingle JN; Pater JL; Martino S; Robert NJ; Muss HB; Piccart MJ; Castiglione M; Shepherd LE; Pritchard KI; Livingston RB; Davidson NE; Norton L; Perez EA; Abrams JS; Cameron DA; Palmer MJ; Tu D
    J Clin Oncol; 2008 Apr; 26(12):1948-55. PubMed ID: 18332475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pilot study of formestane in postmenopausal women with breast cancer.
    Joseph JK; Lim AK
    Med J Malaysia; 1998 Mar; 53(1):37-41. PubMed ID: 10968135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural interferon-beta and tamoxifen in hormone-resistant patients with advanced breast cancer.
    Buzzi E; Brugia M; Trippa F; Rossi G; Trivisonne R; Giustini L; Pinaglia D; Capparella V; Sica G
    Anticancer Res; 1995; 15(5B):2187-90. PubMed ID: 8572622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17.
    Muss HB; Tu D; Ingle JN; Martino S; Robert NJ; Pater JL; Whelan TJ; Palmer MJ; Piccart MJ; Shepherd LE; Pritchard KI; He Z; Goss PE
    J Clin Oncol; 2008 Apr; 26(12):1956-64. PubMed ID: 18332474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.
    Ray-Coquard I; Biron P; Bachelot T; Guastalla JP; Catimel G; Merrouche Y; Droz JP; Chauvin F; Blay JY
    Cancer; 1998 Jan; 82(1):134-40. PubMed ID: 9428489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of CAF plus MPA with CAF plus TAM for advanced or recurrent breast cancer--Kyushu CAFT Study Group of Advanced or Recurrent Breast Cancer].
    Mitsuyama S; Tashiro H; Koga T; Maehara Y; Ogawa M; Kakegawa T; Shimazu H; Sugimachi K; Tomita M; Nakamura Y
    Gan To Kagaku Ryoho; 1995 Dec; 22(14):2073-80. PubMed ID: 8607618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of concurrent versus sequential tamoxifen with radiation therapy in early-stage breast cancer patients undergoing breast conservation treatment.
    Harris EE; Christensen VJ; Hwang WT; Fox K; Solin LJ
    J Clin Oncol; 2005 Jan; 23(1):11-6. PubMed ID: 15545665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
    Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM
    Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chemotherapy of carcinoma of the breast].
    Periti P; Mazzei T
    Minerva Ginecol; 1982 Nov; 34(11):959-62. PubMed ID: 7155423
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.